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Omega-3 polyunsaturated fatty acids (n-3 PUFAs) exert anti-inflammatory effects in sev-
eral liver disorders, including cirrhosis, acute liver failure, and fatty liver disease. To date, 
little is known about their role in immune-mediated liver diseases. In this study, we used 
fat-1 transgenic mice rich in endogenous n-3 PUFAs to examine the role of n-3 PUFAs in 
immune-mediated liver injury. Concanavalin A (Con A) was administered intravenously to 
wild-type (WT) and fat-1 transgenic mice to induce T cell-mediated hepatitis. Reduced 
liver damage was shown in Con A-administrated fat-1 transgenic mice, as evidenced by 
decreased mortality, attenuated hepatic necrosis, lessened serum alanine aminotrans-
ferase activity, and inhibited production of pro-inflammatory cytokines (e.g., TNF-α, IL-6, 
IL-17A, and IFN-γ). In vivo and in vitro studies demonstrated that n-3 PUFAs significantly 
inhibited the activation of hepatic T cells and the differentiation of Th1 cells after Con 
A  challenge. Further studies showed that n-3 PUFAs markedly increased autophagy 
level in Con A-treated fat-1 T cells compared with the WT counterparts. Blocking hepatic 
autophagy activity with chloroquine diminished the differences in T cell activation and 
liver injury between Con A-injected WT and fat-1 transgenic mice. We conclude that n-3 
PUFAs limit Con A-induced hepatitis via an autophagy-dependent mechanism and could 
be exploited as a new therapeutic approach for autoimmune hepatitis.
Keywords: omega-3 polyunsaturated fatty acids, immune-mediated liver injury, concanavalin a-induced hepatitis, 
T cell activation, autophagy
inTrODUcTiOn
Autoimmune hepatitis is a medical problem in which the body’s immune system attacks the liver, 
causing cirrhosis and liver failure (1). Although the etiology is not entirely understood, impaired 
apoptosis and excessive T cell activation are believed to be associated with the pathophysiology of 
autoimmune hepatitis (2, 3). The T cell responses involved in autoimmune hepatitis comprise the 
Abbreviations: ALT, alanine aminotransferase; ALA, alpha-linolenic acid; BSA, bovine serum albumin; CFSE,  5-(and-6)-carboxy 
fluorescein diacetate succinimidyl ester; Con A, Concanavalin A; DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; 
H&E, hematoxylin and eosin; MNCs, mononuclear cells; mTOR, mammalian target of rapamycin; n-3 PUFAs, Omega-3 
polyunsaturated fatty acids; NF-κB, nuclear factor-κB; PI, propidium iodide; PVDF, polyvinylidene fluoride; WT, wild-type.
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predominant IFN-γ-producing Th1 cells over IL-4-producing 
Th2 cells and the reduced frequency and function of regula-
tory T cells (Tregs) (4–7). It is of critical importance to identify 
new immune modulators that can counter-regulate the hepatic 
immune response, especially the T cell response, in autoimmune 
hepatitis.
Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are a col-
lection of polyunsaturated fatty acids, including eicosapentaenoic 
acid (EPA) and docosahexaenoic acid (DHA) from fish and 
alpha-linolenic acid (ALA) in plants (8), which have acknowl-
edged effects on both structural integrity and function of cellular 
membranes. Emerging evidence showed that n-3 PUFAs could 
regulate the inflammatory response by decreasing inflammatory 
cytokines and reactive oxygen production (9). Fat-1 transgenic 
mice, which express the Caenorhabditis elegans fat-1 gene, are 
capable of synthesizing n-3 PUFAs from the n-6 type, leading to 
elevated amounts of n-3 PUFAs in their tissues compared with the 
wild-type (WT) littermates (10). Thus, these mice exhibit more 
anti-inflammatory derivatives generated from n-3 PUFAs (e.g., 
resolvin E1, resolvin D3, protectin D1, and maresin 1), resulting 
in protection against inflammatory disorders in different organs, 
such as allergic airway inflammation, chemically induced colitis, 
pancreatitis, and diabetic neuropathy (11–14). Since fat-1 trans-
genic mice have significant endogenous amounts of n-3 PUFAs 
in their liver tissue (15), the function of n-3 PUFAs in liver 
injury and inflammation has been investigated. Fat-1 transgenic 
mice developed less severe d-galactosamine/lipopolysaccharide 
(d-GalN/LPS)-induced inflammatory liver injury than WT mice, 
associated with a reduction of pro-inflammatory cytokines (e.g., 
TNF-α, IL-1β, IL-6, and IFN-γ) (15). Moreover, tissue n-3 PUFAs 
protected against acute ethanol-induced hepatic steatosis and 
diet-induced fatty liver disease in fat-1 transgenic mice, through 
activation of cholesterol catabolism to bile acid and downregula-
tion of hepatic inflammatory response (16, 17). However, the 
effect of endogenous n-3 PUFAs on liver immune responses that 
involve hepatic T lymphocytes remains unclear.
Intravenous injection of mice with T cell mitogen concanavalin 
A (ConA) induces polyclonal activation of T lymphocytes, result-
ing in a liver-specific inflammatory response (18). This model is 
characterized by elevated serum levels of alanine transaminase 
(ALT) and pro-inflammatory cytokines (e.g., TNF-α, IL-6, and 
IFN-γ), as well as infiltration of T lymphocytes and necrosis of 
hepatocytes in the liver tissue (4, 19). Therefore, Con A-induced 
hepatitis is a well-established murine model that can simulate the 
pathophysiology of human autoimmune hepatitis and has been 
extensively employed to elucidate the underlying mechanisms of 
T cell-mediated autoimmune hepatitis. In this study, we used fat-
1 transgenic mice to explore the protective effect of endogenous 
n-3 PUFAs on liver injury in the model of autoimmune hepatitis 
induced by Con A. The results showed that fat-1 transgenic mice 
were resistant to Con A-induced hepatitis, which attributed to the 
suppressed T cell activation and Th1 differentiation in the pres-
ence of n-3 PUFAs. We also provided evidences that endogenous 
n-3 PUFAs enhanced T cell autophagy upon Con A challenge, 
which may be involved in the inhibition of T cell activation 
and subsequent liver injury. In summary, our findings revealed 
that hepatic n-3 PUFAs controlled T cell responses during 
immune-mediated hepatitis, which may be potentially employed 
as a new therapeutic strategy for autoimmune hepatitis.
MaTerials anD MeThODs
Mice
Wild-type C57BL/6 mice were purchased from the Laboratory 
Animal Center of Southern Medical University (Guangzhou, 
China). Fat-1 transgenic mice were backcrossed with WT C57BL/6 
mice, and the fat-1 genotypes of each animal were characterized 
using isolated genomic DNA from mouse tails by PCR analysis 
as we previously described (20). All animal experiments in this 
study were approved by the Welfare and Ethical Committee for 
Experimental Animal Care of Southern Medical University.
reagents
Con A, chloroquine, and DHA were purchased from Sigma–
Aldrich (St. Louis, MO, USA). Antibodies were obtained from 
Cell Signaling Technology (Danvers, MA, USA), including the 
antibodies against p62 (Cat# 5114), LC3 (D11), phospho-STAT1 
(58D6), STAT1 (D1K9Y), phospho-STAT3 (D3A7), STAT3 
(D3Z2G), phospho-NF-κB p65 (93H1), NF-κB p65 (C22B4), 
and GAPDH (D16H11). Mouse monoclonal antibodies against 
CD3 (145-2C11), CD4 (RM4-5), IFN-γ (XMG1.2), and CD69 
(H1.2F3) were purchased from BD Pharmingen (San Jose, CA, 
USA). Anti-NK1.1 (PK136), anti-CD16/CD32 (2.4G2), goat 
anti-rabbit IgG, and 7-aminoactinomycin D (7-AAD) were from 
MultiSciences (Hangzhou, China). Also, 5-(and-6)-carboxyfluo-
rescein diacetate succinimidyl ester (CFSE) was purchased from 
Invitrogen (San Diego, CA, USA).
con a-induced hepatitis Model
Con A-induced hepatitis was initiated as described previously 
with modification (21). Briefly, Con A (C2010, Sigma–Aldrich) 
was dissolved in PBS at 1 mg/ml, and age-matched mice received 
an intravenous injection of Con A to induce hepatitis. The high 
dose (35  mg/kg body weight) of Con A was used to generate 
survival curves in WT and fat-1 transgenic mice, while the low 
dose (15 mg/kg body weight) of Con A permitted assessment of 
the liver pathology with hematoxylin and eosin (H&E) staining 
and other in vitro assays at indicated time after Con A challenge. 
To test the benefit of dietary n-3 PUFAs in immune-mediated 
liver injury, WT mice were fed with an n-3 PUFAs-enriched 
diet, as we previously described (20), for 3  weeks before Con 
A administration. For autophagy inhibition, chloroquine was 
injected intraperitoneally at the dose of 40 mg/kg body weight 
1 h before Con A administration.
TUnel assay
Formalin-fixed and paraffin-embedded tissue sections of 
liver were deparaffinized in xylene, then gradually rehydrated 
in decreasing concentrations of ethanol and distilled water. 
Subsequently, proteinase K permeabilized sections were sub-
jected to incubation with TdT enzyme and fluorochrome mixture 
(Promega, Madison, WI, USA) for 1 h at 37°C in the dark. After 
DAPI (Roche, Mannheim, Germany) staining, the slides were 
analyzed under a fluorescence microscope.
TaBle 1 | Primers for inflammatory cytokines and T cell-specific transcript factors.
Forward primer (5′–3′) reverse primer (5′–3′)
IFN-γ CATCAGCAACAACATAAGCGTCA CTCCTTTTCCGCTTCCTGA
TNF-α CTCTTCTGCCTGCTGCACTTTG ATGGGCTACAGGCTTGTCACTC
IL-6 TACCACTTCACAAGTCGGAGGC CTGCAAGTGCATCATCGTTGTTC
IL-17A CAGACTACCTCAACCGTTCCAC TCCAGCTTTCCCTCCGCATTGA
IL-4 ATCATCGGCATTTTGAACGAGGTC ACCTTGGAAGCCCTACAGACGA
IL-10 CGGGAAGACAATAACTGCACCC CGGTTAGCAGTATGTTGTCCAGC
T-bet CCACCTGTTGTGGTCCAAGTTC CCACAAACATCCTGTAATGGCTTG
GATA3 CCTCTGGAGGAGGAACGCTAAT GTTTCGGGTCTGGATGCCTTCT
RORγt CCGCTGAGAGGGCTTCAC TGCAGGAGTAGGCCACATTACA
Foxp3 CCTGGTTGTGAGAAGGTCTTCG TGCTCCAGAGACTGCACCACTT
GAPDH CATCACTGCCACCCAGAAGACTG ATGCCAGTGAGCTTCCCGTTCAG
3
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serum alT assay and cytokine 
assessment
Individual mouse serum was collected at different time points 
after Con A injection. Serum alanine aminotransferase (ALT) 
activity was measured with a commercial kit (Jiancheng Biotech, 
Nanjing, China), according to the manufacturer’s instruction. 
Cytokine levels in the sera and cell culture supernatants were 
assessed using commercial ELISA kits purchased from eBiosci-
ence (San Diego, CA, USA).
Western Blotting analysis
Protein samples were separated on SDS-polyacrylamide gels and 
then transferred onto polyvinylidene fluoride (PVDF) membranes 
(Millipore, Billerica, MA, USA). Bovine serum albumin (BSA, 
5%) was used to block non-specific sites of the membranes for at 
least 1 h at room temperature. Subsequently, the membranes were 
incubated overnight at 4°C with primary antibodies, followed by 
incubation with the horseradish peroxidase-conjugated second-
ary antibody for 1 h at room temperature. Finally, the membranes 
were washed three times, and detection of the target protein was 
conducted with enhanced chemiluminescence (Thermo Fisher, 
Carlsbad, CA, USA).
Preparation of liver Mononuclear cells 
and Purification of hepatic T cells
Mouse livers were removed and pressed through a 200-gage stain-
less steel mesh. The filtrate containing non-parenchymal cell was 
centrifuged at 50 × g for 5 min. Supernatants containing mononu-
clear cells (MNCs) were collected, followed by washing once with 
PBS. The cells were resuspended in 30% Percoll (GE Healthcare, 
Uppsala, Sweden) and gently overlaid onto 70% Percoll. After cen-
trifugation at 1000 × g for 20 min, liver MNCs were collected from 
the interphase, washed twice with PBS, and then resuspended for 
further proliferation assay and FACS analysis. T cells were puri-
fied from liver MNCs using mouse T lymphocyte enrichment set 
from BD Biosciences (San Jose, CA, USA).
Flow cytometry
Isolated liver MNCs were resuspended in PBS containing 1% BSA. 
NKT cells and T cells were determined by staining with anti-CD3, 
anti-CD4, anti-NK1.1, and anti-CD69 (BD Pharmingen). For 
detection of IFN-γ and LC3, cells with surface staining were fixed 
and permeabilized by Cytofix/Cytoperm kit (eBioscience), further 
stained with anti-IFN-γ or anti-LC3 antibodies. To evaluate nuclear 
factor-κB (NF-κB) activity in T cells, hepatic MNCs from Con 
A-injected mice were permeabilized by methanol followed stained 
with fluorescence-conjugated antibodies against phospho-NF-κB 
p65 and CD3. T cell apoptosis was monitored by FACS analysis 
using Annexin V/propidium iodide (PI) staining, according to the 
manufacturer’s instruction (Keygen Biotech, Nanjing, China).
isolation of rna and qrT-Pcr analysis
Mice liver or hepatic MNCs’ total RNA was extracted using Trizol 
(Invitrogen) and then transcribed into cDNA using the reverse 
transcription kit (TaKaRa, Dalian, China), as instructed by the 
manufacturer. SYBR Green quantitative RT-PCR was performed 
to determine the gene expression level using a 7900HT fast real-
time PCR system (Applied Biosystems, San Francisco, CA, USA), 
according to the protocols provided with the SYBR Premix EX 
Taq (TaKaRa). The levels of target gene were normalized with 
respect to GAPDH gene expression. The primer sequences used 
in the experiment are shown in Table 1.
In vitro T cell stimulation
Liver MNCs (4 ×  105 per well) were treated with various con-
centration of Con A in the flat-bottomed 96-well plate for 72 h 
for proliferation assay. Supernatants were collected at 48  h for 
cytokine assays using ELISA. Purified hepatic T cells were 
stimulated with 5 μg/ml of Con A for indicated time followed by 
immunoblotting and FACS analysis. In some studies, DHA was 
added 4 h before treatment with Con A.
statistical analysis
The experimental data were evaluated by calculating the 
mean  ±  SD. One-way ANOVA was used for comparisons 
among multiple groups. Differences between two groups within 
experiments were analyzed by Student’s t-test. Comparison of the 
survival curves was performed using the log-rank test. Values of 
p < 0.05 were considered statistically significant.
resUlTs
n-3 PUFas Play a Protective role in con 
a-induced Fulminant hepatitis
To define the role of n-3 PUFAs in Con A-induced hepatitis, 
sex- and age-matched C57BL/6 WT and fat-1 transgenic mice 
FigUre 1 | n-3 PUFas protect mice from con a-induced hepatitis. (a) WT and fat-1 transgenic mice (n = 10) were injected with Con A at the dose of 35 mg/
kg, and overall survival of mice was monitored (p = 0.009). (B–D) A low dose of Con A (15 mg/kg) was injected into WT and fat-1 transgenic mice (n = 5). Serum 
ALT activities in different time points were determined (B). Histological analysis of mouse livers was performed with H&E staining. Scale bars = 100 μm. Bottom 
panels showed the higher-magnification views of the necrotic area. Scale bars = 50 μm. (c). The apoptosis in mice liver tissues was evaluated by fluorescence 
TUNEL staining. Scale bars = 50 μm. (D). *p < 0.05, **p < 0.01. Data are representative of three independent experiments with similar results. (e,F) WT mice were 
injected with Con A (15 mg/kg) after consuming normal diet (ND) or n-3 PUFAs-enriched diet (n-3 PUFAs) for 3 weeks (n = 5 each). Histology of liver (e) and serum 
ALT (F) were examined 24 h following Con A administration. Scale bars = 100 μm. **p < 0.01. Data are representative of two independent experiments with similar 
results.
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were treated with a high dose of Con A (35 mg/kg body weight), 
and the survival rate of mice was determined. Strikingly, all of the 
WT mice died within 60 h. In contrast, 90% of fat-1 transgenic 
mice survived the challenge (Figure 1A), indicating a protective 
role of endogenous n-3 PUFAs against Con A-induced liver 
damage. To evaluate the effect of n-3 PUFAs on liver injury, mice 
received a low dose of Con A (15 mg/kg body weight), followed 
by the examination of serum ALT activity and liver pathological 
changes. Sera collected from fat-1 transgenic mice showed low 
levels of ALT activity compared to that from WT mice after 
FigUre 2 | endogenous n-3 PUFas differentially regulate the expression of cytokines during con a-induced liver injury. (a) Serum levels of IFN-γ, 
TNF-α, IL-6, IL-17A, IL-4, and IL-10 were determined at 0, 6, 12, and 24 h post-Con A administration (n = 5). (B) Relative intrahepatic mRNA expression levels of 
IFN-γ, TNF-α, IL-6, IL-17A, IL-4, and IL-10 were measured by quantitative RT-PCR analysis at 0, 6, 12, and 24 h post-Con A administration and expressed as a 
ratio to GAPDH (n = 5). *p < 0.05, **p < 0.01. Data shown represent three independent experiments with similar results.
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Con A injection (Figure  1B). Liver histological changes were 
examined at 16 h after Con A challenge. The result showed that 
liver tissues from fat-1 transgenic mice displayed less hepato-
cyte necrosis and disseminated hemorrhage than those from 
WT mice (Figure 1C). Besides, the TUNEL positive cells were 
more abundant in the livers of Con A-treated WT mice than 
those from fat-1 transgenic mice, indicating endogenous n-3 
PUFAs could suppress the severe necrosis and apoptosis in the 
liver (Figure 1D). To further verify the protective effect of n-3 
PUFAs on Con A-induced hepatitis, WT mice were fed with n-3 
PUFAs-enriched diet for 3 weeks prior to Con A administration. 
In contrast to mice with normal diet (ND), mice receiving n-3 
PUFAs-enriched diet showed minor liver damage after Con A 
injection as reflected by hepatic pathology (Figure 1E) and serum 
ALT levels (Figure 1F).
Next, we compared the serum levels of cytokines between 
Con A-treated WT and fat-1 transgenic mice to determine the 
protective role of endogenous n-3 PUFAs in Con A-induced 
hepatitis. Attenuated liver damage in fat-1 transgenic mice was 
accompanied by a pronounced reduction of pro-inflammatory 
cytokines (i.e., TNF-α, IFN-γ, IL-6, and IL-17A) and increment of 
the anti-inflammatory cytokine IL-10 in serum, while no signifi-
cant difference in IL-4 was observed between Con A-treated WT 
and fat-1 transgenic mice (Figure 2A). Accordingly, intrahepatic 
mRNA expression of the pro-inflammatory cytokines was signifi-
cantly suppressed in fat-1 transgenic mice compared with those 
in WT mice upon Con A administration (Figure 2B). Also, the 
trend of change in the hepatic expression of IL-10 and IL-4 was 
similar with those in serum between WT and fat-1 transgenic 
mice (Figure 2B).
activation of T cells and the 
Differentiation of Th1 cells are 
suppressed in Fat-1 Transgenic Mice 
Treated with con a
Activation of T cells or NKT cells was also determined in Con 
A-challenged mice. The frequency of T cells and NKT cells 
in the liver was decreased in both WT and fat-1 transgenic 
mice after Con A injection, and no significant difference was 
observed between the two groups (Figure  3A). However, 
hepatic T cells and NKT cells displayed reduced activation in 
Con A-administrated fat-1 transgenic mice compared with 
those in WT counterparts, as indicated by a decreased expres-
sion of CD69 (Figure 3A).
Since IFN-γ and CD4+ Th1 cells differentiation plays a domi-
nant role in Con A-induced liver damage (4, 7), we therefore 
evaluated the IFN-γ-producing immune cells in liver. As shown 
in Figure  3B, Con A-treated fat-1 transgenic mice showed a 
marked decrease in the frequency of IFN-γ-producing CD4+ 
T cells in the livers compared to WT controls. Accordingly, 
liver STAT1 phosphorylation at Tyr701 induced by Con A was 
much lower in fat-1 transgenic mice than that in WT littermates 
(Figure  3C). Meanwhile, reduced STAT3 activation was also 
observed in the liver of Con A-administrated fat-1 transgenic 
mice (Figure 3C), which was possibly due to the reduced IL-6 
level in serum of fat-1 transgenic mice. T-bet is a transcription 
factor critical to the development of CD4+ Th1 cells (22). We 
demonstrated that T-bet was greatly suppressed in the liver of 
fat-1 transgenic mice compared to their WT counterparts, sug-
gesting that endogenous n-3 PUFAs could suppress the differen-
tiation of Th1 cells in Con A-induced hepatitis. By contrast, the 
Th2 transcript factor GATA3 expression was comparable in these 
two groups with or without Con A administration. Surprisingly, 
the Th17 transcription factor RORγt expression was lower, while 
the Treg transcript factor Foxp3 expression was higher in liver 
from fat-1 transgenic mice than those from WT mice after Con 
A injection (Figure 3D).
suppression of the In vitro activation of 
hepatic T cells by n-3 PUFas
To determine whether endogenous n-3 PUFAs influence the Con 
A-induced T cell activation in vitro, hepatic MNCs isolated from 
WT and fat-1 transgenic mice were stimulated with different 
concentrations of Con A. As shown in Figure 4A, [3H] thymidine 
FigUre 3 | endogenous n-3 PUFas suppress intrahepatic nKT and T cells activation and Th1 cells differentiation upon con a administration. Hepatic 
MNCs were isolated from the liver of WT and fat-1 transgenic mice (n = 5) at indicated time after Con A (15 mg/kg) injection. (a) The lymphocyte population and its 
activation were analyzed by FACS using anti-NK1.1, anti-CD3, and anti-CD69 antibodies. (B) Intracellular IFN-γ production of hepatic CD4+ T cells was compared 
by FACS analysis. (c) Levels of STAT1 and STAT3 proteins and phospho-STAT proteins in liver lysates from WT and fat-1 transgenic mice after injection of Con A 
were analyzed by Western blotting. GAPDH was served as a loading control. (D) Relative intrahepatic mRNA expression of T cell transcript factors, including T-bet, 
GATA3, RORγt, and Foxp3, was measured by quantitative RT-PCR analysis at 0, 6, 12, and 24 h post-Con A administration and expressed as a ratio to GAPDH. 
*p < 0.05, **p < 0.01, N.S., not significant. One of three independent experiments is shown.
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FigUre 4 | n-3 PUFas inhibit con a-stimulated T cell activation in vitro. (a) Hepatic MNCs from WT and fat-1 transgenic mice were stimulated with different 
concentration of Con A in vitro. The proliferation response and cytokine production of T cells were determined by [3H] thymidine uptake and ELISA assay, 
respectively. **p < 0.01. Data are representative of three independent experiments. (B,c) Hepatic MNCs were treated with Con A (5 μg/ml) for various time. Cell 
extracts were then subjected to western blotting analysis with the antibodies against phospho-STAT1, phospho-STAT3, STAT1, and STAT3. One of the three 
independent experiments is shown (B). Relative mRNA expression of T cell transcript factors, including T-bet, GATA3, RORγt, and Foxp3, was measured by 
quantitative RT-PCR analysis and expressed as a ratio to GAPDH. *p < 0.05, **p < 0.01, N.S., not significant. One of the three independent experiments is shown 
(c). (D,e) Liver MNCs isolated from WT mice were cultured with Con A (2.5 μg/ml) in the presence of indicated doses of DHA. T cell proliferation was measured by 
CFSE dilution (D), and cytokine levels were determined by ELISA assays (e). **p < 0.01, compared to the group without DHA. Data are representative of three 
independent experiments. (F) Liver MNCs isolated from WT mice were stimulated with Con A at different concentrations with or without DHA (50 μmol/L) incubation, 
and the cytokine production was evaluated by ELISA. **p < 0.01, compared to the group without DHA. Data shown represent three independent experiments with 
similar results.
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FigUre 5 | endogenous n-3 PUFas enhance autophagy activity in immune cells upon con a administration. (a) Autophagy associated protein LC3 and 
p62 in liver tissues were analyzed by western blotting analysis at indicated time after Con A (15 mg/kg) injection into WT and fat-1 transgenic mice (n = 5). (B) The 
frequency of LC3-producing hepatic T cells was assessed at 6 h after Con A (15 mg/kg) injection by intercellular staining and FACS analysis. (c,D) Reduced NF-κB 
activation in the livers of Con A-administrated fat-1 transgenic mice (n = 5). Levels of phospho-NF-κB p65 and total NF-κB p65 protein in liver lysates from WT and 
fat-1 transgenic mice were examined by immunoblotting at indicated time following Con A (15 mg/kg) injection (c). The activity of NF-κB in hepatic T cells from WT 
and fat-1 transgenic mice was evaluated at 6 h after Con A (15 mg/kg) injection by FACS analysis (D). Data are representative of three independent experiments.
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uptake and IFN-γ production were reduced in Con A-stimulated 
liver MNCs from fat-1 transgenic mice compared to those from 
WT mice. Moreover, the phosphorylation of STAT1 or STAT3 
was much lower in Con A-stimulated liver MNCs derived from 
fat-1 transgenic mice than those in WT controls (Figure  4B). 
Besides, the mRNA expression of T-bet and RORγt was greatly 
suppressed, whereas Foxp3 mRNA expression was increased in 
the Con A-treated liver MNCs from fat-1 transgenic mice com-
pared to those from WT mice. In contrast, the GATA3 expression 
was comparable in both groups with or without Con A treatment 
(Figure 4C).
Furthermore, we stimulated liver MNCs from WT mice 
with Con A in the absence or presence of DHA, which is a 
form of n-3 PUFAs. DHA was found strongly to inhibit the 
T cell proliferation (Figure 4D) and cytokines (i.e., IFN-γ and 
IL-2) production (Figure  4E) in a dose-dependent manner. 
Likewise, we evaluated the function of DHA on hepatic T cells 
activation induced by different concentration of Con A. The 
result also showed that DHA has an inhibitory effect on T cell 
activation, as indicated by decreased secretion of IFN-γ and 
IL-2 (Figure 4F).
n-3 PUFas enhance autophagy activity in 
immune cells upon con a administration
Autophagy serves as a cellular protective mechanism, helping 
maintain normal cellular functioning and homeostasis (23). In 
acute liver injury, autophagy plays a protective role, and autophagic 
cell death occurs in the failure of adaptation (24). To investigate 
whether autophagy is associated with the protective effect of n-3 
PUFAs in Con A-induced hepatitis, we assessed the expression of 
proteins related to autophagy in the liver post-Con A injection. 
The result showed that LC3-II level dramatically increased in liver 
tissue from Con A-treated fat-1 transgenic mice compared with 
that from WT mice (Figure 5A). Also, the expression of p62 was 
low in fat-1 transgenic mice as compared with that in WT mice. 
Indeed, FACS analysis showed a much higher frequency of LC3 
positive T cells in the liver of fat-1 transgenic mice compared to 
their WT counterparts (Figure 5B). These results suggested that 
n-3 PUFAs enhanced the autophagy activity in hepatic T cells 
from mice with Con A treatment. Given the interplay between 
autophagy process and NF-κB signaling pathway is necessary 
for the maintenance of cellular homeostasis (25), we examined 
the NF-κB activity in the liver tissue and hepatic T cell upon 
Con A stimulation. Reduced phosphorylation of NF-κB p65 
was observed in the liver of Con A-treated fat-1 transgenic mice 
(Figure  5C). Also, NF-κB activity in hepatic T cells from Con 
A-injected fat-1 transgenic mice was lower than those from WT 
counterparts (Figure 5D).
Next, we evaluated the autophagy levels in hepatic MNCs 
stimulated with Con A in vitro. Isolated hepatic MNCs and T cells 
from fat-1 transgenic mice exhibited higher autophagy activity 
compared with those from WT mice upon Con A stimulation 
(Figures  6A,B). Additionally, DHA elevated the expression of 
LC3 in hepatic MNCs and T cells induced by Con A incubation, as 
showed by immunoblotting and FACS analysis (Figures 6C,D). 
To further define whether n-3 PUFAs directly affect autophagy 
activity in T cells, hepatic T cells were purified from WT mice 
and stimulated with Con A in vitro in the presence or absence 
of DHA. The result showed that DHA significantly increased 
autophagy activity and suppressed NF-κB p65 phosphorylation 
in Con A-stimulated hepatic T cells (Figure 6E). Autophagy has 
FigUre 6 | n-3 PUFas increase autophagy levels in hepatic T cells 
stimulated with con a in vitro. (a) Autophagy-associated protein LC3 in 
Con A (5 μg/ml)-stimulated hepatic MNCs from WT and fat-1 transgenic mice 
were analyzed by western blotting analysis at indicated time. (B) The 
frequency of LC3-producing hepatic T cells was assessed at 12 h after Con 
A stimulation by intercellular staining and then FACS analysis. (c) Autophagy-
associated protein LC3 in Con A (5 μg/ml)-cultured hepatic MNCs in the 
presence or absence of DHA (50 μmol/L) by western blotting analysis. (D) 
The frequency of LC3-producing hepatic T cells was assessed at 12 h after 
Con A stimulation with or without DHA treatment by intercellular staining and 
then FACS analysis. Data shown represent three independent experiments 
with similar results. (e) Autophagy-associated protein LC3 and NF-κB p65 in 
Con A (5 μg/ml)-stimulated hepatic T cells with or without DHA (50 μmol/L) 
treatment were analyzed by western blotting analysis at indicated time. Data 
are representative of three independent experiments. (F) Hepatic T cells 
purified from WT mice were incubated with Con A (5 μg/ml) in the presence 
or absence of DHA (50 μmol/L) for 24 h. Cells apoptosis were determined by 
Annexin V/PI staining. Data shown represent three independent experiments 
with similar results.
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also been associated with the regulation of various cell death 
pathways, most notably apoptosis (26). Thus, we evaluated the 
effect of n-3 PUFAs on Con A-induced cell apoptosis in hepatic 
T cells, and the result showed that DHA increased apoptosis of 
Con A-activated T cells (Figure 6F). It indicated that n-3 PUFAs 
limit T cell immune response at least partially by promoting cell 
apoptosis of activated T cells.
inhibition of autophagy with chloroquine 
abrogates the Protective Function of n-3 
PUFas in con a-induced hepatitis
Chloroquine inhibits autophagy as it raises the lysosomal pH, 
thus blocking the fusion between autophagosomes and lysosomes 
(27). To further study the role of autophagy in the protective 
function of n-3 PUFAs in Con A-induced liver damage, WT 
and fat-1 transgenic mice received 40  mg/kg of chloroquine 
to block autophagy before Con A administration, followed by 
histological and serum analysis. The severity of liver damage was 
comparable between Con A-injected WT and fat-1 transgenic 
mice with chloroquine pretreatment (Figure 7A). Additionally, 
the sera collected from WT and fat-1 transgenic mice showed no 
significant difference in the levels of ALT activity (Figure 7B) and 
pro-inflammatory cytokines (i.e., IFN-γ and TNF-α) (Figure 7C). 
Analysis of hepatic MNCs showed that the frequency and the acti-
vation of NKT cells or T cells were similar between WT and fat-1 
transgenic mice upon Con A challenge with autophagy inhibition 
(Figure 7D). The percentage of IFN-γ-producing CD4+ Th1 cells 
in fat-1 transgenic mice was almost the same with those in WT 
mice (Figure 7E). Moreover, no significant difference was seen 
between WT and fat-1 transgenic mice in the phosphorylation 
of STAT1 and STAT3 as well as the NF-κB activity (Figure 7F). 
These data suggested that the protective effect of endogenous n-3 
PUFAs on Con A-induced hepatitis is dependent on autophagy 
in regulating T cell activation.
DiscUssiOn
Omega-3 polyunsaturated fatty acids have been reported to atten-
uate various liver diseases and cancer (15–17, 28). However, the 
function of n-3 PUFAs in autoimmune hepatitis remains unclear. 
In the present study, we demonstrate that endogenous production 
of n-3 PUFAs in fat-1 transgenic mice reduces the Con A-induced 
T cell-mediated hepatic injury. Our studies revealed the inhibi-
tory effect of endogenous n-3 PUFAs on Con A-induced T cell 
activation and CD4+ Th1 differentiation. Furthermore, we also 
provided the evidence that n-3 PUFAs enhanced autophagy 
activity, resulting in protection from severe liver damage due to 
the acute overreaction of the immune system.
Previous in vitro and in vivo studies showed that n-3 PUFAs 
reduced pro-inflammatory cytokines production secreted from 
monocytes and macrophages. For example, cell culture studies 
showed that n-3 PUFAs can suppress the production of TNF-α 
by MNCs (29) and IL-6 and IL-8 by endothelial cells (9, 30). 
Schmöcker et al. demonstrated that fat-1 transgenic mice devel-
oped less severe macrophage-mediated liver injury induced by 
d-GalN/LPS than WT mice, as indicated by decreased plasma 
TNF-α level, ALT activity, and liver pathology (15). Here, we 
demonstrated that endogenous n-3 PUFAs also inhibited the 
pro-inflammatory cytokines produced by activated T cells. These 
results extended our understanding of the negative regulatory 
function of n-3 PUFAs on inflammatory responses triggered by 
various immune cells. It is quite important to notice that the liver 
macrophages are responsible for the proliferation of CD4+ T cells 
and generation of IFN-γ-producing Th1 cells in Con A-induced 
hepatitis (31). Therefore, it is possible that modulation of T cell 
function in vivo partially owing to the effect of n-3 PUFAs on liver 
macrophages, and further investigations are warranted.
Since T cells activation plays a significant role in Con 
A-induced hepatitis (18, 21), the amelioration of Con A-induced 
liver injury in fat-1 transgenic mice may also be related to the 
selective inhibition of activated T lymphocytes by n-3 PUFAs. 
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FigUre 7 | chloroquine abolishes the protective function of endogenous n-3 PUFas in con a-induced liver injury. WT and fat-1 transgenic mice (n = 5) 
received 40 mg/kg body weight of chloroquine by intraperitoneal injection before Con A (15 mg/kg) challenge. (a–c) Histology of liver was examined at 24 h 
following Con A administration. Scale bars = 100 μm. Bottom panels showed the higher-magnification views of the necrotic area. Scale bars = 50 μm (a). Serum 
ALT (B) and cytokine levels (c) were evaluated at indicated time. N.S., not significant. One of the three independent experiments is shown. (D,e) The percentage of 
CD69+ T cells and NKT cells (D) as well as the frequency of IFN-γ-producing CD4+ T cells (e) were assessed at 12 h after Con A injection by FACS analysis of 
hepatic MNCs. Data shown represent three independent experiments with similar results. (F) Levels of phospho-STAT1, phospho-STAT3, phospho-NF-κB p65, 
STAT1, STAT3, and NF-κB p65 protein in the liver from Con A-administrated mice with chloroquine pretreatment were analyzed using immunoblotting assay at 
indicated time. One of the two independent experiments is shown.
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We determined that endogenous n-3 PUFAs suppressed the 
activation of T cells and NKT cells during Con A challenge. On 
autoimmune hepatitis, CD4+ T cells represent the predominant 
population of T cells infiltrating into the liver, and Th1-like 
cytokines (e.g., IFN-γ and TNF-α) contribute to hepatic injury 
(4, 19). It has been noted that n-3 PUFAs supplementation 
attenuated Th1 cell-mediated delayed type hypersensitivity 
responses in healthy human volunteers (32). Here, we observed 
remarkably suppressed polarization of Th1 cells and reduced 
expression of Th1 transcription factor, T-bet, in liver from Con 
A-injected fat-1 transgenic mice. Additionally, we also observed 
reduced activation of Th17-related STAT3 as well as expression 
of Th17 transcript factor (RORγt) in liver and decreased IL-17A 
level in serum from Con A-administrated fat-1 transgenic mice. 
A recent study showed that long-term administration of n-3 
PUFAs amplified the number of Tregs in the liver, and abundant 
IL-10 expression in n-3 PUFAs-feed mice might be partially 
contributing to the generation of hepatic Tregs (33). It is worth 
noting that the expressions of Treg transcript factor Foxp3 and 
immunomodulatory cytokine IL-10 were significantly increased 
in fat-1 transgenic mice compared to their WT littermates after 
Con A administration. Our observations support the conclu-
sion that hepatic n-3 PUFAs could influence the differentiation 
of CD4+ T cells into various effector subsets in the liver during 
immune-mediated hepatitis, and therefore modulate the patho-
genesis of autoimmune and chronic hepatitis.
The autophagy process is often used to eliminate damaged 
or unwanted organelles and also remove intracellular microbial 
pathogens (23), which play a significant role in the normal liver 
physiology, as well as in the pathogenesis of liver disease (24, 
34). However, the influence of autophagy in the pathogenesis of 
T cell-mediated hepatitis remains controversial. In the present 
study, we provided the evidence that autophagy activity is associ-
ated with the function of endogenous n-3 PUFAs in modulating 
the severity of liver injury induced by Con A. NF-κB signaling, 
which regulates the transcription of critical effector T cell genes, 
is crucial for T cell activation (35). Autophagy has been described 
to downregulate NF-κB activity in effector T cells, via degrading 
the adaptor protein Bcl10, which assembles a signaling complex 
with Carma-1 and the paracaspase Malt1 for NF-κB activation 
(36). We found that n-3 PUFAs promoted autophagy activity and 
inhibited NF-κB p65 phosphorylation in T cells. This effect may 
be associated with the reduced T cell activation in fat-1 transgenic 
mice upon Con A administration. Nevertheless, additional stud-
ies are required to elucidate the precise mechanism of autophagy 
in modulating T cell-NF-κB activity during Con A-induced 
hepatitis.
Importantly, mammalian target of rapamycin (mTOR) 
has been identified as a crucial regulator of cell metabolism 
regulating metabolism and plays a critical role in driving T cell 
differentiation and function (37). Inhibition of mTOR activity 
by rapamycin promotes T cell anergy even in the presence of 
costimulatory activation (38). Emerging evidence showed that 
increased autophagy is linked to mTOR inhibition in senescent 
cells (39). The previous study demonstrated that n-3 PUFAs rap-
idly and efficiently suppressed both mTOR complex 1 (mTORC1) 
and mTORC2 and their downstream signaling (20). Hence, we 
speculate that hepatic n-3 PUFAs may regulate mTOR-autophagy 
axis in the liver during immune-mediated hepatitis.
In summary, we demonstrate a role for endogenous n-3 PUFAs 
in the alleviation of T cell-mediated hepatic injury. Increased 
T cell autophagy activity induced by n-3 PUFAs restrains Con 
A-induced T cell activation and inflammatory liver injury. These 
findings substantiate the concept that n-3 PUFAs have potential 
clinical application to attenuate immune-mediated liver injury.
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